Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

•This ESMO Clinical Practice Guideline provides key recommendations for managing immunotherapy-related toxicity.•The guideline covers assessment, diagnosis and treatment of the most common and severe immunotherapy-related toxicities.•Recommended assessment and treatment algorithms according to the g...

Full description

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 33; no. 12; pp. 1217 - 1238
Main Authors Haanen, J., Obeid, M., Spain, L., Carbonnel, F., Wang, Y., Robert, C., Lyon, A.R., Wick, W., Kostine, M., Peters, S., Jordan, K., Larkin, J.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2022
Subjects
ESMO Clinical Practice Guideline
Follow-Up Studies
Humans
Immunologic Factors
immunotherapy
Immunotherapy - adverse effects
side-effects
toxicity
treatment
toxicity
treatment
side-effects
ESMO Clinical Practice Guideline
immunotherapy
Online AccessGet full text

Cover

More Information
Summary:•This ESMO Clinical Practice Guideline provides key recommendations for managing immunotherapy-related toxicity.•The guideline covers assessment, diagnosis and treatment of the most common and severe immunotherapy-related toxicities.•Recommended assessment and treatment algorithms according to the grade of toxicity are provided.•The authors comprise a multidisciplinary group of experts from different institutions in Europe, Australia and the USA.•Recommendations are based on available scientific data and the authors’ collective expert opinion.
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2022.10.001